Clinical-pathological changes in differentiated thyroid cancer (DTC) over time (1997-2010): Data from the University Hospital "maggiore della Carità" in Novara

Endocrine

Volumn 42, Issue 2, 2012, Pages 382-390

  Pagano, L ^a   Caputo, M ^a   Sama M T ^a   Garbaccio, V ^a   Zavattaro, M ^a   Mauri, M G ^b   Prodam, F ^a   Marzullo, P ^a   Boldorini, R ^a   Valente, G ^a   Aimaretti, G ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

Author keywords

Differentiated thyroid cancer; Environmental risk; Thyroiditis

Indexed keywords

LEVOTHYROXINE; RADIOACTIVE IODINE; RECOMBINANT THYROTROPIN; THYROGLOBULIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; DISTANT METASTASIS; FEMALE; FOLLOW UP; GOITER; HISTOPATHOLOGY; HUMAN; IODINE DEFICIENCY; ITALY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TEXTILE WORKER; THYROIDECTOMY; THYROIDITIS; TUMOR RECURRENCE; UNIVERSITY HOSPITAL;

EID: 84867403435     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9612-4     Document Type: Article

References (39)

1. J.A. Sipos, E.L. Mazzaferri, Thyroid cancer epidemiology and prognostic variables. Clin. Oncol. 22, 395-404 (2010)
2. B.A. Kilfoy, T. Zheng, T.R. Holford et al., International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control 20(5), 525-531 (2009)
3. Associazione Italiana Registro Tumori (AIRTUM) Available from http://www.registri-tumori.it/cms/?q=sede-tiroide (2011). Accessed 14 October 2011
4. Centro di Riferimento per l'Epidemiologia e la Prevenzione Oncologica in Piemonte (CPO-Piemonte). Available from http://www.cpo.it/dationcologici/ registro-tum2011.htm (2011). Accessed 14 October 2011
5. F. Pacini, M.G. Castagna, L. Brilli et al., Differentiated thyroid cancer: ESMOClinical reccomendations for diagnosis, treatment and follow up. Ann. Oncol. 19(2), 99-101 (2008)
6. E.L. Mazzaferri, Managing low risk thyroid cancer. Endocr. Pract. 13(5), 499 (2007)
7. D.E. Thompson, K. Mabuchi, E. Ron et al., Cancer incidence in atomic bomb survivors, part II: solid tumors, 1958-1987. Radiat. Res. 137, S17-S67 (1994)
8. v. Gomez Segovia, H.J. Gallowitsch, E. Kresnik et al., Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria: 1984-2001. Histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: population-based age-stratified analysis on thyroid carcinoma incidence. Thyroid 14(4), 277-286 (2004)
9. A. Belfiore, G.L. La Rosa, G. Padova et al., The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine-deficient area. Cancer 60, 3096-3102 (1987)
10. R.A. Ott, A.R. McCall, H. Jarosz et al., The incidence of thyroid carcinoma in Hashimoto's thyroiditis. Am. Surg. 53, 442-445 (1987)
11. G. Pellegriti, F. De Vathaire, C. Scollo et al., Papillary thyroid cancer incidence in the volcanic area of Sicily. J. Natl. Cancer Inst. 101, 1575-1583 (2009)
12. E.Y. Wong, R. Ray, D.L. Gao et al., Reproductive history, occupational exposures, and thyroid cancer risk among women textile workers in Shangai, China. Int. Arch. Occup. Environ. Health 79, 251-258 (2006)
13. WHO. Prevention and control of iodine deficiency disorders. Fifty-second world healthy assembly. Provisonal agenda item 13. Geneva; World Health Organization (1999)
14. F. Pacini, M. Schlumberger, H. Dralle et al., European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur. J. Endocrinol. 154, 787-803 (2006)
15. D.S. Cooper, G.M. Doherty, B.R. Haugen et al., Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16(2), 109-141 (2006)
16. H. Gharib, E. Papini, R. Paschke, for the AACE/AME/ETA Task Force on Thyroid Nodules et al., American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association. Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules. Endocr. Pract. 16(1), 1-43 (2010)
17. American Joint Committee on Cancer: Chapter 8: Thyroid in: AJCC cancer staging handbook. 6th edition. Spinger, New York, pp 89-98 (2002)
18. WHO, UNICEF, ICCIDD, Indicators for assessing iodine deficiency disorders and their control through salt iodination (World Health Organization, Geneva, 1992)
19. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper, D.S., Doherty, G.M., Haugen, B.R. et al. Revised American Thyroid Association Management Guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11): 1167-1214 (2009)
20. AJCC Seventh Edition Staging Series: Staging Head and Neck Cancers - transitioning to the seventh edition of the AJCC Cancer Staging Manual. American Joint Committee on Cancer Web site. Available from http://www.cancerstaging. org/products/ajccguide.pdf. Accessed 14 October 2011
21. S. Lonati, A. Rapa, G. Di Dio et al., Iodine status in historically iodine deficiency area. Minerva Pediatr. 58(3), 255-256 (2006)
22. L. Enewold, K. Zhu, E. Ron et al., Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol. Biomarkers Prev. 18, 784-791 (2009)
23. R. Elisei, E. Molinaro, L. Agate et al., Are the clinical and pathological features of differentiated thyroid carcinoma really changed over last 35 years? Study on 4187 patients from a single Italian Institution to answer to this question. J. Clin. Endocrinol. Metab. 95(4), 1516-1527 (2010)
24. M. Rizzo, R.T. Rossi, O. Bonaffini et al., Increased annual frequency of Hashimoto's thyroiditis between years 1988 and 2007 at a cytological unit of Sicily. Ann. Endocrinol. (Paris) 71(6), 525-534 (2010)
25. S. Benvenga, F. Trimarchi, Changed presentation of Hashimoto's thyroiditis in north-eastern Sicily and Calabria (southern Italy) based on a 31-year experience. Thyroid 18(4), 429-441 (2008)
26. G. Mazziotti, L.D. Premawardhana, A.B. Parkes et al., Evolution of thyroid autoimmunity during iodine prophylaxis - the Sri Lankan experience. Eur. J. Endocrinol. 149(2), 103-110 (2003)
27. P. Vitti, E. Martino, F. Aghini-Lombardi et al., Thyroid volume measurement by ultrasound in children as a tool for the assessment of mild iodine deficiency. J. Clin. Endocrinol. Metab. 79(2), 600-603 (1994)
28. F. Pacini, T. Vorontsova, E.P. Demidchik et al., Post Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and French. J. Clin. Endocrinol. Metab. 82(11), 3563-3569 (1997)
29. M.J. Favus, A.B. Scneider, M.E. Stachura et al., Thyroid cancer occurring as late as consequence of head-and-neck irradiation. Evaluation of 1056 patients. N. Engl. J. Med. 294, 1019-1025 (1976)
30. L. García-Pascual, M.J. Barahona, M. Balsells et al., Complex thyroid nodules with nondiagnostic fine needle aspiration cytology: histopathologic outcomes and comparison of the cytologic variants (cystic vs. acellular). Endocrine. 39(1), 33-40 (2011)
31. L. García-Pascual, M. Balsells, M. Fabbi et al., Prognostic factors and follow-up of patients with differentiated thyroid carcinoma with false negative or nondiagnostic FNAC before surgery Comparison with a control group. Endocrine 40(3), 423-431 (2011)
32. D.T. Hughes, M.R. Haymart, B.S. Miller et al., The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid 21(3), 231-236 (2011)
33. J.M. Stulak, C.S. Grant, D.R. Farley et al., Value of preoperative ultrasonography in surgical management of initial and reoperative papillary thyroid cancer. Arch. Surg. 141, 489-494 (2006)
34. T.Y. Ho, M.J. Liou, K.J. Lin et al., Prevalence and significance of thyroid uptake detected by 18F-FDG PET. Endocrine 40(2), 297-302 (2011)
35. Y. Ito, T. Higashiyama, Y. Takamura et al., Risks factors for recurrence to the limph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J. Surg. 31, 2085-2091 (2007)
36. E.L. Mazzaferri, S.M. Jhiang, Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am. J. Med. 97, 418-428 (1994)
37. E. Sampson, J.D. Brierley, L.W. Le et al., Clinical management and outcome of papillary and follicular (differentiated thyroid cancer) presenting with distant metastasis at diagnosis. Cancer 110, 1451-1456 (2007)
38. M.G. Castagna, L. Brilli, T. Pilli et al., Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels. J. Clin. Endocrinol. Metab. 93(1), 76-81 (2008)
39. R.M. Tuttle, T. Hernan, J. Shas et al., Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by The New Thyroid Association Staging System. Thyroid 20(12), 1341-1349 (2010)